综述
ENGLISH ABSTRACT
哺乳动物雷帕霉素靶蛋白信号通路与眼科疾病相关性的研究进展
张桂铭
刘红玲
傅少颖 [综述]
作者及单位信息
·
DOI: 10.3760/cma.j.issn.2095-0160.2015.11.018
Advance in research on the relationship between mammalian target of rapamycin signaling pathway and ophthalmic diseases
Zhang Guiming
Liu Hongling
Fu Shaoying
Authors Info & Affiliations
Zhang Guiming
Department of Ophthalmology, The First Affiliated Hospital of Harbin Medical University, Harbin 150000, China
Liu Hongling
Fu Shaoying
·
DOI: 10.3760/cma.j.issn.2095-0160.2015.11.018
924
9
0
0
0
0
PDF下载
APP内阅读
摘要

哺乳动物雷帕霉素靶蛋白(mTOR)是一种高度进化保守的蛋白激酶,控制细胞生长、生长因子和细胞能量的形成,参与营养、新陈代谢及老化过程,近年发现mTOR信号通路与细胞生长、调控蛋白质合成代谢密切相关,已成为肿瘤形成、代谢紊乱、神经系统疾病和炎症等疾病的重要通路。就mTOR及通路介导的眼科疾病进行综述。

哺乳动物雷帕霉素靶蛋白;信号通路;雷帕霉素;眼科疾病
ABSTRACT

Mammalian target of rapamycin (mTOR) is a highly evolutionary conserved protein kinase and plays a critical role in the regulation of cell growth, growth factors and cell energy, and thus contributes to the formation of nutrition, metabolism and aging processes.Recent studies found that mTOR signaling pathway is associated with cell cycle, protein synthesis and metabolism, and it is an important pathway of diseases such as development of tumor, metabolic disorders, nervous system disease and inflammation.The relationship between mTOR signaling pathway and ophthalmic diseases was reviewed in this article.

Mammalian target of rapamycin;Signaling pathway;Rapamycin;Ophthalmic diseases
Fu Shaoying, Email: mocdef.6ab21gniyoahsuf
引用本文

张桂铭,刘红玲,傅少颖. 哺乳动物雷帕霉素靶蛋白信号通路与眼科疾病相关性的研究进展[J]. 中华实验眼科杂志,2015,33(11):1048-1051.

DOI:10.3760/cma.j.issn.2095-0160.2015.11.018

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)广泛存在于各种生物细胞中,是一种负责调节细胞生长和营养代谢、生长因子和细胞能量的重要信号,与生物的新陈代谢和年龄相关性疾病密切相关 [ 1 ]。1991年Heitman等 [ 2 ]在啤酒酵母菌中发现TOR蛋白,1994年Takei等 [ 3 ]分别在哺乳动物中也发现此蛋白,命名为mTOR蛋白。近年研究发现,哺乳动物在mTOR信号调节异常时会发生癌症、肥胖、2型糖尿病和退行性神经病变等疾病。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Cornu M , Albert V , Hall MN . mTOR in aging, metabolism, and cancer[J]. Curr Opin Genet Dev, 2013,23(1):53-62. doi: 10.1016/j.gde.2012.12.005 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Heitman J , Movva NR , Hall MN . Tagets for cell cycle arrest by the immunosuppressant rapamycin in yeast[J]. Science, 1991,253(5022):905-909.
返回引文位置Google Scholar
百度学术
万方数据
[3]
Takei N , Nawa H . mTOR signaling and its roles in normal and abnormal brain development[J/OL]. Front Mol Neurosci, 2014,7:28[2015-06-14]. http: //journal.frontiersin.org/article/10.3389/fnmol.2014.00028.doi: 10.3389/fnmol.2014.00028.
返回引文位置Google Scholar
百度学术
万方数据
[4]
Shields CL , Shields JA . Recent developments in the management of retinoblastoma[J]. J Pediatr Ophthalmol Strabismus, 1999,36(1):8-18.
返回引文位置Google Scholar
百度学术
万方数据
[5]
Cafferkey R , Young PR , McLaughlin MM ,et al. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity[J]. Mol Cell Biol, 1993,13(10):6012-6023. doi: 10.1128/MCB.13.10.6012 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Gibbons JJ , Abraham RT , Yu K . Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth[J]. Semin Oncol, 2009,36Suppl 3:S3-S17. doi: 10.1053/j.seminoncol.2009.10.011 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Laplante M , Sabatini DM . mTOR signaling at a glance[J]. J Cell Sci, 2009,122(Pt 20):3589-3594. doi: 10.1242/jcs.051011 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Parkhitko AA , Favorova OO , Khabibullin DI ,et al. Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging[J]. Biochemistry, 2014,79(2):88-101. doi: 10.1134/S0006297914020023 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Sarbassov DD , Guertin DA , Ali SM ,et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex[J]. Science, 2005,307(5712):1098-1101.
返回引文位置Google Scholar
百度学术
万方数据
[10]
Wullschleger S , Loewith R , Hall MN . TOR signaling in growth and metabdism[J]. Cell, 2006,124(3):471-484.
返回引文位置Google Scholar
百度学术
万方数据
[11]
Contreras AG , Dormond O , Edelbauer M ,et al. mTOR—Understanding theclinical effects[J]. Transplant Proc, 2008,40(10 Suppl):S9-S12. doi: 10.1016/j.transproceed.2008.10.011 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Faivre S , Kroemer G , Raymond E . Current development of mTOR inhibitosas anticancer agents[J]. Nat Rev Drug Discov, 2006,5(8):671-688. doi: 10.1038/nrd2062 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Gordon BS , Kazi AA , Coleman CS ,et al. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells[J]. Cell Signal, 2014,26(3):461-467. doi: 10.1016/j.cellsig.2013.11.035 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Takahara1 T , Maeda T . Evolutionarily conserved regulation of TOR signalling[J]. J Biochem, 2013,154(1):1-10. doi: 10.1093/jb/mvt047 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Choe J , Oh N , Park S ,et al. Translation initiation on mRNA bound by nuclear cap-binding protein complex CBP80/20 requires interaction between CBP80/20-dependent translation initiation factor and eukaryotic translation initiation factor 3g[J]. J Biol Chem, 2012,287(22):18500-18509. doi: 10.1074/jbc.M111.327528 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Foldenauer ME , McClellan SA , Berger EA ,et al. Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection[J]. J Immunol, 2013,190(11):5649-5658. doi: 10.4049/jimmunol.1203094 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Zapata G , Racca L , Tau J ,et al. Topical use of rapamycin in herpetic stromal keratitis[J]. Ocul Immunol Inflamm, 2012,20(5):354-359. doi: 10.3109/09273948.2012.709575 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Shin YJ , Hyon JY , Choi WS ,et al. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation[J]. Invest Ophthalmol Vis Sci, 2013,54(7):4452-4458. doi: 10.1167/iovs.13-11684 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Yoshizaki A , Yanaba K , Yoshizaki A ,et al. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycininduced mouse models of systemic sclerosis[J]. Arthritis Rheum, 2010,62(8):2476-2487. doi: 10.1002/art.27498 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Zhu J , Wu J , Frizell E ,et al. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis[J]. Gastroenterology, 1999,117(5):1198-1204.
返回引文位置Google Scholar
百度学术
万方数据
[21]
Lee KS , Ko DA , Kim ES ,et al. Bevacizumab and rapamycin can decrease corneal opacity and apoptotic keratocyte number following photorefractive keratectomy[J]. Invest Ophthalmol Vis Sci, 2012,53(12):7645-7653. doi: 10.1167/iovs.12-10494 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Milani BY , Milani FY , Park DW ,et al. Rapamycin inhibits the production of myofibroblasts and reduces corneal scarring after photorefractive keratectomy[J]. Invest Ophthalmol Vis Sci, 2013,54(12):7424-7430. doi: 10.1167/iovs.13-12674 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Abraham RT , Wiederrecht GJ . Immunopharmacology of rapamycin[J]. AnnuRev Immunol, 1996,14:483-510. doi: 10.1146/annurev.immunol.14.1.483 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Olsen TW , Benegas NM , Joplin AC ,et al. Rapamycin inhibits corneal allo graft rejection and neovascularization[J]. Arch Ophthalmol, 1994,112(11):1471-1475. doi: 10.1001/archopht.1994.01090230085026 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Kwon YS , Hong HS , Kim JC ,et al. Inhibitory effect of rapamycin on corneal neovascularizaion in vitro and in vivo[J]. Invest Opthalmol Vis Sci, 2005,46(2):454-460. doi: 10.1167/iovs.04-0753 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Shi W , Gao H , Xie L ,et al. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits[J]. Invest Ophthalmol Vis Sci, 2006,47(8):3339-3344. doi: 10.1167/iovs.05-1425 .
返回引文位置Google Scholar
百度学术
万方数据
[27]
Ikeda E , Hikita N , Eto K ,et al. Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis[J]. Jpn J Ophthalmol, 1997,41(6):396-402.
返回引文位置Google Scholar
百度学术
万方数据
[28]
Liu H , Feng G , Wu L ,et al. The effects of rapamycin on lens epithdelial cell proliferation, migration, and matrix formation: an in vitro study[J]. Mol Vis, 2010,16:1646-1653.
返回引文位置Google Scholar
百度学术
万方数据
[29]
Abraham RT , Wiederrecht GJ . Immunopharmacology of rapamycin[J]. Ann Rev Immunol, 1996,14(1):483-510. doi: 10.1146/annurev.immunol.14.1.483 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
Liu H , Wu L , Fu S ,et al. Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes[J]. Graefe's Arch Clin Exp Ophthalmol, 2009,247(6):801-807. doi: 10.1007/s00417-008-1007-0 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Zhao C , Yasumura D , Li X ,et al. mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice[J]. J Clin Invest, 2011,121(1):369-383. doi: 10.1172/JCI44303 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
Schieke SM , Phillips D , McCoy JP Jr,et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity[J]. J Biol Chem, 2006,281(37):27643-27652. doi: 10.1074/jbc.M603536200 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
Huang Q , Sheibani N . High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs[J]. Am J Physiol Cell Physiol, 2008,295(6):C1647-C1657. doi: 10.1152/ajpcell.00322.2008 .
返回引文位置Google Scholar
百度学术
万方数据
[34]
Feng Z , Zhang H , Levine AJ ,et al. The coordinate regulation of the p53 and mTOR pathways in cells[J]. Proc Natl Acad Sci U S A, 2005,102(23):8204-8209. doi: 10.1073/pnas.0502857102 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
Groszer M , Erickso R , Scripture-Adams DD ,et al. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo[J]. Science, 2001,294(5549):2186-2189. doi: 10.1126/science.1065518 .
返回引文位置Google Scholar
百度学术
万方数据
[36]
Wu X , Senechal K , Neshat MS ,et al. The PTEN/MMAC1 tumor suppress or phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway[J]. Proc Natl Acad Sci U S A, 1998,95(26):15587-15591. doi: 10.1073/pnas.95.26.15587 .
返回引文位置Google Scholar
百度学术
万方数据
[37]
Kaplan MJ , Ellis CN , Beta-Csorgo Z ,et al. Sytemie toxicity following administration of sirolimus(formly rapamycin)for psoriasis: association of capillary leak syndrome with apoptosis of lesional lymphocytes[J]. Arch Dematol, 1999,135(5):553-557. doi: 10.1001/archderm.135.5.553 .
返回引文位置Google Scholar
百度学术
万方数据
[38]
Hidalgo M , Rowinsky EK . The rapamycin-sensitive signal transduction pathway as a target for cancer therapy[J]. Oncogene, 2000,19(56):6680-6686.
返回引文位置Google Scholar
百度学术
万方数据
[39]
Jaworski J , Sheng M . The growing role of mTOR in neuronal development and plasticity[J]. Mol Neurobiol, 2006,34(3):205-219. doi: 10.1385/MN: 34: 3: 205 .
返回引文位置Google Scholar
百度学术
万方数据
[40]
Park KK , Liu K , Hu Y ,et al. PTEN/mTOR and axon regeneration[J]. Exp Neurol, 2010,223(1):45-50. doi: 10.1016/j.expneurol.2009.12.032 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
傅少颖,Email: mocdef.6ab21gniyoahsuf
B
国家自然科学基金项目 (30970749、81301325)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号